Drug-Induced Intersticial Nephritis. Clinical Case

Q3 Medicine
Paulina Tekoriutė, Monika Matuliauskaitė, L. Jonaitis
{"title":"Drug-Induced Intersticial Nephritis. Clinical Case","authors":"Paulina Tekoriutė, Monika Matuliauskaitė, L. Jonaitis","doi":"10.15388/Amed.2021.28.2.14","DOIUrl":null,"url":null,"abstract":"5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function.","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"28 1","pages":"355 - 359"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Lituanica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15388/Amed.2021.28.2.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function.
药物诱导的间质性肾炎。临床病例
5-氨基水杨酸(5-ASA)制剂广泛用于治疗炎症性肠病。最常用的药物是美沙拉秦。总的来说,它是一种非常安全的药物,几乎没有副作用。这种药的一个罕见副作用是间质性肾炎。停药后,肾功能通常会恢复。但是,如果长时间没有检测到损坏,可能会发生不可逆转的变化。在这篇文章中,我们介绍了一例美沙拉秦诱导的In的临床病例。一名患有溃疡性结肠炎20年的56岁男子因美沙拉秦引发的急性肾衰竭入院。一年前,患者被诊断为美沙拉秦诱导的间质性肾炎,并停止了美沙拉秦的治疗。溃疡性结肠炎的症状恶化,患者独立决定开始服用美沙拉秦,这导致他的健康状况恶化,肾功能受损。美沙拉秦已经停用,对急性肾衰竭进行了额外的治疗,包括血液透析。肾功能恢复,患者出院接受溃疡性结肠炎的进一步治疗和肾功能监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Medica Lituanica
Acta Medica Lituanica Medicine-General Medicine
CiteScore
0.70
自引率
0.00%
发文量
33
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信